In this study, we show that C:15 administration for 3 weeks prior to DSS induction elicits a protective effect against colitis severity, specifically protecting mice against weight loss and resulting in lower fecal MPO activity when compared to non-treated mice. The gene discussed is MPO; the disease is colitis.